cilastatin has been researched along with Leukocytopenia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K | 1 |
Fujita, K; Hatae, Y; Kon-No, M; Nagashima, T; Nakadate, H; Suzuki, Y; Takahashi, Y; Takase, A; Takeda, T; Wagatsuma, Y | 1 |
Bruserud, O | 1 |
1 trial(s) available for cilastatin and Leukocytopenia
Article | Year |
---|---|
[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Leukemia; Leukopenia; Male; Neoplasms; Pneumonia; Sepsis | 1993 |
2 other study(ies) available for cilastatin and Leukocytopenia
Article | Year |
---|---|
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins | 2004 |
Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cilastatin; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Interleukin-2; Leukemia, Myeloid, Acute; Leukopenia; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes | 2000 |